Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA

Enter the characters shown in the image.

User menu

You are here

  1. Department of Statistics
  2. Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

TitlePredicting gadolinium enhancement status in MS patients eligible for randomized clinical trials
Publication TypeJournal Article
Year of Publication2005
AuthorsBarkhof, F, Held, U, Simon, JH, Daumer, M, Fazekas, F, Filippi, M, Frank, JA, Kappos, L, Li, D, Menzler, S, Miller, DH, Petkau, J, Wolinsky, J
JournalNeurology
Volume65
Pagination1447–1454